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Current evidence from experimental animals suggests that the
colonic crypt is a clonal unit derived from, and maintained
by, a single cell (Griffiths et al., 1988). Treatment of normal
female TO strain mice with the colon-specific carcinogen
dimethylhydrazine (DMH) results in a histochemically
demonstrable loss of activity of the X-linked enzyme glucose-
6-phosphate dehydrogenase (G6PD) in single, randomly dis-
tributed colonic crypts. This phenotypic change is uniform
within the affected crypts, and its frequency is related to the
dose of DMH treatment, strongly suggesting that it is the
result of a carcinogen induced mutation at the G6PD locus
on the active X-chromosome of a single primary crypt stem
cell (Griffiths et al., 1988).
A similar crypt-restricted phenotypic change has been de-
monstrated in normal human large bowel mucosa using the
mild periodic acid-Schiff (mPAS) technique (Sugihara & Jass,
1986). This histochemical method distinguishes between 0-
acetylated sialomucins, which are mPAS-negative, and non-
0-acetylated sialomucins which stain a magenta colour (Veh
et al., 1982). Sugihara and Jass (1986) found that in most
human colons the goblet cell mucus is O-acetylated and
mPAS-negative but that in a small proportion of individuals
it is non-O-acetylated and diffusely mPAS-positive. However,
in some cases with mPAS-negative colonic mucus glyco-
proteins they observed scattered individual mPAS-positive
crypts. They were uncertain of the significance of this but
interpreted it as a 'functional metaplasia'. A similar
phenomenon has been identified by Hughes et al. (1986), who
described a focal loss of immunoreactivity to a monoclonal
antibody (3NM) directed against colonic goblet cells, again
confined to scattered crypts in the human large intestine.
Because the crypt-restricted phenotypic alterations de-
scribed in these two reports are similar to the mutagen-
induced loss of G6PD activity in the colonic crypts of experi-
mental mice, we considered that they may result from crypt
stem cell mutation. If this were correct, the frequency of
affected crypts would increase with exposure to environmen-
tal mutagens, and be age-related. The change might also
occur more frequently in subjects with colorectal cancer. We
have investigated this using the mPAS technique on his-
tologically normal areas of resection specimens of the sig-
moid colon and upper rectum from 30 adults (mean age 71.8
years, range 55-91) with primary large intestinal adenocar-
cinoma, 30 age-matched controls (mean age 71.3 years, range
52-90) with benign conditions of the sigmoid colon (diver-
ticular disease 27, volvulus 3), and 18 infants or children
(mean age 25 months, range 2 days to 9 years) with Hir-
schsprung's disease (16), intestinal atresia (1) or colonic dup-
lication (1). One block of formalin-fixed, paraffin-embedded
tissue from each resection margin of the colectomy specimens
was taken and 5 im histological sections were cut at 50pm
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intervals. Each section was then stained using the mPAS
method (Veh et al., 1982). In nine cases (three from each
patient group) two adjacent levels were cut, one being stained
by the mPAS technique and the other by the periodic acid-
phenylhydrazine-Schiff (PAPS) technique, a second method
which distinguishes O-acetylated (PAPS-negative) from non-
O-acetylated (magenta-coloured) sialomucins (Spicer, 1961).
All of the sections were then examined by light microscopy
and the staining reaction of the goblet cell mucus in every
crypt recorded. A deep magenta staining reaction was
regarded as positive while an absent or very pale washed out
pink staining reaction was regarded as negative for both
histochemical techniques. The number of crypt profiles in
each section was counted manually by placing a transparent
acetate sheet over the viewing screen of a Visopan micro-
scope and marking each crypt seen in longitudinal, transverse
and oblique section whilst counting with a hand-held tally.
Sufficient levels were examined to ensure that a total of at
least 2,000 separate crypts were assessed in every case, the
average number of crypts examined being 2,523 in the cases
with carcinoma, 2,313 in the age-matched controls and 2,375
in the infant cases.
None of the sections showed any morphological abnor-
mality of the colonic mucosa on light microscopy. Examina-
tion of the adjacent sections stained by the mPAS and PAPS
methods showed identical patterns of staining. The results
obtained with the mPAS method are summarised in Table I.
Three patterns of staining were observed in specimens
from adult subjects. In the majority (39/60) the goblet cell
mucin of all the crypts examined gave a uniform negative
mPAS staining reaction while a minority (5/60) showed a
diffusely positive staining reaction throughout the mucosa. In
the third group (16/60) occasional positively stained crypts
were scattered in an otherwise negatively staining mucosa,
with an apparently random distribution (Figure 1). Such
positive crypts usually occurred singly, although a total of
five patches of between two and six adjacent positive crypts
were found in four cases. In the great majority of affected
crypts all the goblet cells were uniformly positive (Figure 2).
However, in five crypts from four of the colons (7% of all
positive crypts in a negatively staining background) there was
partial involvement affecting one sector of the crypt cir-
cumference (Figure 3). The average frequency of individual
Table I
Adult cases
Benign
conditions Carcinoma Infant cases
Mean age (years) 71.3 71.8 2.08
Range 52-90 55-91 2 days to 9 years
Uniformly positive mucosa 3/30 2/30 2/18
Negative mucosa with 8/30 8/30 0/18
focal crypt positivity
Uniformly negative mucosa 19/30 20/30 16/18
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Figure 1 A single mPAS-positive crypt in a negatively staining
mucosa. mPAS stain, x 250.
Figure 2 An isolated mPAS-positive crypt seen in longitudinal
section showing uniform staining of goblet cells from the base of
the crypt to the luminal surface. mPAS stain, x 200.
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Figure crypt transverse section showing a sectorial dist-
mPAS-positive goblet cells. mPAS stain, x 500.
positive crypts was 13 x 10' (range 5 x 10-4 to 24 x 10-4)
in cases with carcinoma and 15 x 10-4 (range 5 x I0- to
36 x 10-4) in the cases without carcinoma. The difference
between the groups is not statistically significant (Wilcoxon
matched-pair signed-ranks test).
The colonic mucosa of the 18 infants and children revealed
only two patterns of staining reaction, either uniformly
negative (16/18) or uniformly positive (2/18) mPAS staining.
No individual positive crypts in a negatively staining mucosa
were seen. The difference in the observed frequency of single
positive crypts between the adults and children is statistically
significant (X2 test, P<0.01).
Two aspects of the study need explanation, the occurrence
of two mucosal phenotypes (91% mPAS negative, 9% mPAS
positive) and the occurrence in adults but not children of
very small numbers of individual mPAS positive crypts in a
proportion of colons with otherwise uniformly mPAS-
negative colonic mucosa. It has been shown that the degree
of 9-O-acetylation of mouse red blood cell membrane sialic
acids is regulated by an autosomal gene, inbred strains being
either high or low acetylators (Varki & Kornfield, 1980). We
propose that the heterogeneity seen in human colonic
sialomucins is also the result of an autosomal gene,
homozygous dominant and heterozygous individuals having
O-acetylated (mPAS-negative) sialomucins and homozygous
recessives having non-O-acetylated (mPAS-negative)
sialomucins. The frequency of the two phenotypes in this
study is identical to that found by Sugihara and Jass (1986).
As the population frequency of the mPAS-positive
phenotype, and hence the homozygous recessive genotype, is
0.09 the Hardy-Weinberg law predicts that the other
genotypic frequencies in the British population would be 0.49
for homozygous dominant and 0.42 for heterozygous individ-
uals, assuming that O-acetylation of sialomucins is controlled
by a single gene. A single stem cell mutation in heterozygous
individuals would result in the conversion of a crypt from the
mPAS-negative to the mPAS-positive phenotype, whereas a
single mutation in a homozygous individual would have no
phenotypic effect. We propose, therefore, that the appearance
of scattered mPAS-positive crypts in a mPAS-negative back-
ground is the result of somatic mutation in the stem cell
responsible for the maintenance of the colonic crypt in
heterozygous individuals. Since approximately 25/60 of our
adults are expected to be heterozygous, single positive crypts
in 16/60 adults suggests that fixed mutations at this locus
have occurred in the colonic mucosa of at least 60% of the
population at a mean age of 71 years. The failure to demon-
strate such positive crypts in mPAS-negative colons from
infants and children supports the view that the change is due
to an acquired mutation. No significant difference in the
frequency of these crypts was found between adults with or
without carcinoma, but the number of observations is not
great enough to enable any firm conclusion to be drawn.
It is of interest to compare the frequency of phenotypically
altered crypts found in the present study (mean 14 x 10-4)
with those described in previous reports. The only other
relevant human investigation is that of Hughes et al. (1986),
who found scattered 3NM-negative crypts in the sigmoid
colon of five individuals (age unstated) at a mean frequency
of 20 x 10-4. In mice, Griffiths et al. (1988) found that DMH
induced a dose-related, crypt-restricted loss of G6PD activity
in the colons of young (14-35 week) animals, reaching a
frequency of 8.4 x 10-4 after 21 weekly injections, but found
no spontaneously altered crypts in control mice of the same
age. On the other hand, Winton et al. (1988), using loss of
lectin-binding as a phenotypic marker of mutation in small
intestinal crypts of a different strain of mice, found a spon-
taneous mutation rate of approximately 1 x 10-4 at 6 weeks
of age and 6 x 10-4 at 26 weeks. Since the various studies
described have used different species, different target organs,
subjects of different ages, and different phenotypic markers it
is inappropriate to make quantitative comparisons between
them. However, it remains of interest that no spontaneous
mutation was seen when G6PD was used as a marker. It
might be that this is merely a reflection of the young age of
the mice examined in the G6PD study. Nevertheless, it is
known that mutations are not evenly distributed across the
genome, and it may be that genes controlling essential
housekeeping enzymes such as G6PD are relatively spared or
that genes controlling terminal* differentiation, such as those
studied by ourselves, Hughes et al. (1986) and Winton et al.
(1988), may be more sensitive. It is also possible that changes
affecting the pattern of gene expression (so-called epimuta-
tions) may be relevant with these differentiation markers.
However, until more data are available, in particular direct
comparisons using different markers in the same tissues of
animals of the same age and species, further speculation is
unrewarding.
The altered phenotype in the great majority of mPAS-
positive crypts in a negative background was uniform and384 C.E. FULLER et al.
confined to a single crypt, similar to the carcinogen-induced
crypt restricted loss of G6PD activity described experiment-
ally in mice (Griffiths et al., 1988), suggesting that human
colonic crypts, like those of the mouse, are maintained by a
single stem cell. However, a minority (7%) of altered crypts
in the human colon showed partial, usually sectorial, loss of
O-acetylation (Figure 3). The low frequency of partial crypt
involvement makes it unlikely that it is due to the presence of
multiple stem cells in the crypts. It is more likely that partial
involvement is due to mutation in a daughter cell and that it
is a transient phenomenon.
The rare finding of patches of two to six adjacent positive
crypts in otherwise mPAS-negative colons has three possible
explanations. The first, and least likely, is that adjacent
crypts have undergone identical chance mutations. The
second is that the affected crypts represent an 'embryological'
patch resulting from a mutation during fetal or early life in a
single cell that gives rise to a group of adult crypts; such
patches can be well visualised in X-linked heterozygous
animals (Griffiths et al., 1988). The failure to find such
patches in the colons of infants and children also makes this
explanation unlikely. The third, and most likely, is that the
groups of mPAS-positive crypts result by regenerative crypt
neogenesis from a single mutated crypt in an area ofmucosal
damage.
We conclude that we have demonstrated somatic mutation
in the human colon, by studying loss of enzyme activity in a
common polymorphism of O-acetylated sialomucins. Our
findings suggest that, in humans as in mice, individual col-
onic crypts are maintained by a single stem cell.
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